nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—SLCO1B1—Quinidine—malaria	0.0699	0.107	CbGbCtD
Sirolimus—CYP3A5—Artemether—malaria	0.0577	0.0888	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Quinine—malaria	0.0466	0.0717	CbGbCtD
Sirolimus—CYP3A7—Quinine—malaria	0.0466	0.0717	CbGbCtD
Sirolimus—CYP3A4—Clindamycin—malaria	0.0461	0.0709	CbGbCtD
Sirolimus—CYP3A7—Quinidine—malaria	0.041	0.063	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Quinidine—malaria	0.041	0.063	CbGbCtD
Sirolimus—CYP3A7—Dapsone—malaria	0.0353	0.0544	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dapsone—malaria	0.0353	0.0544	CbGbCtD
Sirolimus—CYP3A5—Quinine—malaria	0.035	0.0538	CbGbCtD
Sirolimus—CYP3A5—Dapsone—malaria	0.0265	0.0408	CbGbCtD
Sirolimus—CYP3A4—Sulfadiazine—malaria	0.0265	0.0407	CbGbCtD
Sirolimus—ABCB1—Quinine—malaria	0.0228	0.035	CbGbCtD
Sirolimus—CYP3A4—Artemether—malaria	0.0225	0.0346	CbGbCtD
Sirolimus—CYP3A4—Proguanil—malaria	0.0212	0.0326	CbGbCtD
Sirolimus—CYP3A4—Doxycycline—malaria	0.0201	0.0309	CbGbCtD
Sirolimus—ABCB1—Quinidine—malaria	0.02	0.0308	CbGbCtD
Sirolimus—CYP3A4—Quinine—malaria	0.0136	0.021	CbGbCtD
Sirolimus—CYP3A4—Quinidine—malaria	0.012	0.0184	CbGbCtD
Sirolimus—CYP3A4—Dapsone—malaria	0.0103	0.0159	CbGbCtD
Sirolimus—EIF4E—hematopoietic system—malaria	0.00604	0.0693	CbGeAlD
Sirolimus—EIF4E—kidney—malaria	0.00495	0.0568	CbGeAlD
Sirolimus—MTOR—blood plasma—malaria	0.00423	0.0485	CbGeAlD
Sirolimus—EIF4E—digestive system—malaria	0.0042	0.0482	CbGeAlD
Sirolimus—EIF4E—blood—malaria	0.004	0.0459	CbGeAlD
Sirolimus—FKBP1A—blood plasma—malaria	0.0038	0.0436	CbGeAlD
Sirolimus—SLCO1B1—blood plasma—malaria	0.00322	0.037	CbGeAlD
Sirolimus—EIF4E—liver—malaria	0.00313	0.0359	CbGeAlD
Sirolimus—EIF4E—brain—malaria	0.00248	0.0285	CbGeAlD
Sirolimus—MTOR—hematopoietic system—malaria	0.00234	0.0268	CbGeAlD
Sirolimus—FKBP1A—hematopoietic system—malaria	0.0021	0.0241	CbGeAlD
Sirolimus—MTOR—kidney—malaria	0.00192	0.022	CbGeAlD
Sirolimus—SLC47A1—hematopoietic system—malaria	0.00181	0.0207	CbGeAlD
Sirolimus—SLCO1B1—hematopoietic system—malaria	0.00178	0.0205	CbGeAlD
Sirolimus—FKBP1A—kidney—malaria	0.00172	0.0198	CbGeAlD
Sirolimus—CYP3A5—blood plasma—malaria	0.00165	0.019	CbGeAlD
Sirolimus—MTOR—digestive system—malaria	0.00162	0.0186	CbGeAlD
Sirolimus—MTOR—blood—malaria	0.00155	0.0178	CbGeAlD
Sirolimus—FGF2—brain—malaria	0.00151	0.0174	CbGeAlD
Sirolimus—MTOR—bone marrow—malaria	0.0015	0.0172	CbGeAlD
Sirolimus—SLC47A1—kidney—malaria	0.00148	0.017	CbGeAlD
Sirolimus—SLCO1B1—kidney—malaria	0.00146	0.0168	CbGeAlD
Sirolimus—FKBP1A—digestive system—malaria	0.00146	0.0168	CbGeAlD
Sirolimus—FKBP1A—blood—malaria	0.00139	0.016	CbGeAlD
Sirolimus—FKBP1A—bone marrow—malaria	0.00135	0.0155	CbGeAlD
Sirolimus—CYP3A7—liver—malaria	0.00135	0.0155	CbGeAlD
Sirolimus—SLC47A1—digestive system—malaria	0.00126	0.0144	CbGeAlD
Sirolimus—CYP3A4—blood plasma—malaria	0.00124	0.0143	CbGeAlD
Sirolimus—SLCO1B1—digestive system—malaria	0.00124	0.0142	CbGeAlD
Sirolimus—MTOR—liver—malaria	0.00121	0.0139	CbGeAlD
Sirolimus—SLC47A1—blood—malaria	0.0012	0.0137	CbGeAlD
Sirolimus—SLCO1B1—blood—malaria	0.00118	0.0136	CbGeAlD
Sirolimus—CYP3A7-CYP3A51P—liver—malaria	0.00115	0.0131	CbGeAlD
Sirolimus—FKBP1A—liver—malaria	0.00109	0.0125	CbGeAlD
Sirolimus—MTOR—brain—malaria	0.000961	0.011	CbGeAlD
Sirolimus—SLC47A1—liver—malaria	0.000936	0.0107	CbGeAlD
Sirolimus—SLCO1B1—liver—malaria	0.000924	0.0106	CbGeAlD
Sirolimus—CYP3A5—hematopoietic system—malaria	0.000915	0.0105	CbGeAlD
Sirolimus—ABCB1—blood plasma—malaria	0.000879	0.0101	CbGeAlD
Sirolimus—FKBP1A—brain—malaria	0.000864	0.00991	CbGeAlD
Sirolimus—CYP3A5—kidney—malaria	0.00075	0.00861	CbGeAlD
Sirolimus—SLC47A1—brain—malaria	0.000742	0.00852	CbGeAlD
Sirolimus—CYP3A4—hematopoietic system—malaria	0.000687	0.00788	CbGeAlD
Sirolimus—CYP3A5—digestive system—malaria	0.000636	0.0073	CbGeAlD
Sirolimus—CYP3A5—blood—malaria	0.000606	0.00696	CbGeAlD
Sirolimus—CYP3A4—kidney—malaria	0.000563	0.00646	CbGeAlD
Sirolimus—ABCB1—hematopoietic system—malaria	0.000486	0.00558	CbGeAlD
Sirolimus—CYP3A4—digestive system—malaria	0.000478	0.00548	CbGeAlD
Sirolimus—CYP3A5—liver—malaria	0.000474	0.00544	CbGeAlD
Sirolimus—CYP3A4—blood—malaria	0.000455	0.00522	CbGeAlD
Sirolimus—ABCB1—kidney—malaria	0.000398	0.00457	CbGeAlD
Sirolimus—CYP3A4—liver—malaria	0.000356	0.00408	CbGeAlD
Sirolimus—ABCB1—digestive system—malaria	0.000338	0.00388	CbGeAlD
Sirolimus—Dermatitis—Proguanil—malaria	0.000337	0.00172	CcSEcCtD
Sirolimus—Headache—Proguanil—malaria	0.000335	0.00171	CcSEcCtD
Sirolimus—Haemoglobin—Quinidine barbiturate—malaria	0.000331	0.00169	CcSEcCtD
Sirolimus—Haemoglobin—Pentoxifylline—malaria	0.00033	0.00169	CcSEcCtD
Sirolimus—Immune system disorder—Quinine—malaria	0.000329	0.00169	CcSEcCtD
Sirolimus—Immune system disorder—Quinidine—malaria	0.000329	0.00169	CcSEcCtD
Sirolimus—Haemorrhage—Quinidine barbiturate—malaria	0.000329	0.00169	CcSEcCtD
Sirolimus—Mediastinal disorder—Quinidine—malaria	0.000329	0.00168	CcSEcCtD
Sirolimus—Mediastinal disorder—Quinine—malaria	0.000329	0.00168	CcSEcCtD
Sirolimus—Haemorrhage—Pentoxifylline—malaria	0.000329	0.00168	CcSEcCtD
Sirolimus—Hallucination—Quinidine barbiturate—malaria	0.000328	0.00168	CcSEcCtD
Sirolimus—Chills—Quinidine—malaria	0.000327	0.00168	CcSEcCtD
Sirolimus—Chills—Quinine—malaria	0.000327	0.00168	CcSEcCtD
Sirolimus—Urinary tract disorder—Quinidine barbiturate—malaria	0.000325	0.00167	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000323	0.00166	CcSEcCtD
Sirolimus—Urethral disorder—Quinidine barbiturate—malaria	0.000323	0.00165	CcSEcCtD
Sirolimus—ABCB1—blood—malaria	0.000322	0.0037	CbGeAlD
Sirolimus—Insomnia—Sulfadiazine—malaria	0.000321	0.00164	CcSEcCtD
Sirolimus—Flatulence—Clindamycin—malaria	0.000319	0.00163	CcSEcCtD
Sirolimus—Malnutrition—Quinine—malaria	0.000318	0.00163	CcSEcCtD
Sirolimus—Malnutrition—Quinidine—malaria	0.000318	0.00163	CcSEcCtD
Sirolimus—Nausea—Proguanil—malaria	0.000317	0.00163	CcSEcCtD
Sirolimus—Visual impairment—Quinidine barbiturate—malaria	0.000317	0.00162	CcSEcCtD
Sirolimus—Back pain—Clindamycin—malaria	0.000313	0.0016	CcSEcCtD
Sirolimus—ABCB1—bone marrow—malaria	0.000312	0.00358	CbGeAlD
Sirolimus—Muscle spasms—Clindamycin—malaria	0.000311	0.00159	CcSEcCtD
Sirolimus—Decreased appetite—Sulfadiazine—malaria	0.000308	0.00158	CcSEcCtD
Sirolimus—Tinnitus—Quinidine barbiturate—malaria	0.000307	0.00157	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Sulfadiazine—malaria	0.000306	0.00157	CcSEcCtD
Sirolimus—Cardiac disorder—Quinidine barbiturate—malaria	0.000305	0.00156	CcSEcCtD
Sirolimus—Anaemia—Clindamycin—malaria	0.000299	0.00153	CcSEcCtD
Sirolimus—Tremor—Quinine—malaria	0.000297	0.00152	CcSEcCtD
Sirolimus—Tremor—Quinidine—malaria	0.000297	0.00152	CcSEcCtD
Sirolimus—Immune system disorder—Quinidine barbiturate—malaria	0.000297	0.00152	CcSEcCtD
Sirolimus—Immune system disorder—Pentoxifylline—malaria	0.000297	0.00152	CcSEcCtD
Sirolimus—Mediastinal disorder—Quinidine barbiturate—malaria	0.000297	0.00152	CcSEcCtD
Sirolimus—Chills—Quinidine barbiturate—malaria	0.000295	0.00151	CcSEcCtD
Sirolimus—Cough—Dapsone—malaria	0.000292	0.0015	CcSEcCtD
Sirolimus—Agitation—Quinine—malaria	0.000292	0.00149	CcSEcCtD
Sirolimus—Agitation—Quinidine—malaria	0.000292	0.00149	CcSEcCtD
Sirolimus—Angioedema—Quinine—malaria	0.00029	0.00149	CcSEcCtD
Sirolimus—Angioedema—Quinidine—malaria	0.00029	0.00149	CcSEcCtD
Sirolimus—Gastrointestinal pain—Sulfadiazine—malaria	0.00029	0.00149	CcSEcCtD
Sirolimus—Leukopenia—Clindamycin—malaria	0.00029	0.00148	CcSEcCtD
Sirolimus—Malnutrition—Quinidine barbiturate—malaria	0.000287	0.00147	CcSEcCtD
Sirolimus—Syncope—Quinidine—malaria	0.000285	0.00146	CcSEcCtD
Sirolimus—Syncope—Quinine—malaria	0.000285	0.00146	CcSEcCtD
Sirolimus—Leukopenia—Quinidine—malaria	0.000284	0.00146	CcSEcCtD
Sirolimus—Leukopenia—Quinine—malaria	0.000284	0.00146	CcSEcCtD
Sirolimus—Flatulence—Pentoxifylline—malaria	0.000282	0.00144	CcSEcCtD
Sirolimus—Tension—Quinidine barbiturate—malaria	0.000281	0.00144	CcSEcCtD
Sirolimus—Tension—Pentoxifylline—malaria	0.000281	0.00144	CcSEcCtD
Sirolimus—Palpitations—Quinine—malaria	0.000281	0.00144	CcSEcCtD
Sirolimus—Palpitations—Quinidine—malaria	0.000281	0.00144	CcSEcCtD
Sirolimus—Abdominal pain—Sulfadiazine—malaria	0.00028	0.00144	CcSEcCtD
Sirolimus—Body temperature increased—Sulfadiazine—malaria	0.00028	0.00144	CcSEcCtD
Sirolimus—Hypertension—Clindamycin—malaria	0.000279	0.00143	CcSEcCtD
Sirolimus—Loss of consciousness—Quinidine—malaria	0.000279	0.00143	CcSEcCtD
Sirolimus—Loss of consciousness—Quinine—malaria	0.000279	0.00143	CcSEcCtD
Sirolimus—Nervousness—Quinidine barbiturate—malaria	0.000278	0.00143	CcSEcCtD
Sirolimus—Nervousness—Pentoxifylline—malaria	0.000278	0.00142	CcSEcCtD
Sirolimus—Back pain—Pentoxifylline—malaria	0.000277	0.00142	CcSEcCtD
Sirolimus—Muscle spasms—Pentoxifylline—malaria	0.000275	0.00141	CcSEcCtD
Sirolimus—Discomfort—Clindamycin—malaria	0.000272	0.00139	CcSEcCtD
Sirolimus—Chest pain—Quinine—malaria	0.00027	0.00138	CcSEcCtD
Sirolimus—Myalgia—Quinidine—malaria	0.00027	0.00138	CcSEcCtD
Sirolimus—Myalgia—Quinine—malaria	0.00027	0.00138	CcSEcCtD
Sirolimus—Chest pain—Quinidine—malaria	0.00027	0.00138	CcSEcCtD
Sirolimus—Tremor—Quinidine barbiturate—malaria	0.000268	0.00138	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000268	0.00138	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000268	0.00138	CcSEcCtD
Sirolimus—Tremor—Pentoxifylline—malaria	0.000268	0.00137	CcSEcCtD
Sirolimus—Tachycardia—Dapsone—malaria	0.000267	0.00137	CcSEcCtD
Sirolimus—Ill-defined disorder—Pentoxifylline—malaria	0.000265	0.00136	CcSEcCtD
Sirolimus—Anaemia—Pentoxifylline—malaria	0.000264	0.00135	CcSEcCtD
Sirolimus—Anaphylactic shock—Clindamycin—malaria	0.000264	0.00135	CcSEcCtD
Sirolimus—Agitation—Quinidine barbiturate—malaria	0.000263	0.00135	CcSEcCtD
Sirolimus—Agitation—Pentoxifylline—malaria	0.000263	0.00135	CcSEcCtD
Sirolimus—Angioedema—Quinidine barbiturate—malaria	0.000262	0.00134	CcSEcCtD
Sirolimus—Angioedema—Pentoxifylline—malaria	0.000261	0.00134	CcSEcCtD
Sirolimus—Hypersensitivity—Sulfadiazine—malaria	0.000261	0.00134	CcSEcCtD
Sirolimus—Confusional state—Quinidine—malaria	0.000261	0.00134	CcSEcCtD
Sirolimus—Confusional state—Quinine—malaria	0.000261	0.00134	CcSEcCtD
Sirolimus—Oedema—Quinidine—malaria	0.000259	0.00133	CcSEcCtD
Sirolimus—Oedema—Quinine—malaria	0.000259	0.00133	CcSEcCtD
Sirolimus—Thrombocytopenia—Clindamycin—malaria	0.000259	0.00132	CcSEcCtD
Sirolimus—Malaise—Pentoxifylline—malaria	0.000258	0.00132	CcSEcCtD
Sirolimus—Syncope—Quinidine barbiturate—malaria	0.000257	0.00132	CcSEcCtD
Sirolimus—Leukopenia—Quinidine barbiturate—malaria	0.000256	0.00131	CcSEcCtD
Sirolimus—Leukopenia—Pentoxifylline—malaria	0.000256	0.00131	CcSEcCtD
Sirolimus—Shock—Quinine—malaria	0.000255	0.00131	CcSEcCtD
Sirolimus—Shock—Quinidine—malaria	0.000255	0.00131	CcSEcCtD
Sirolimus—Nervous system disorder—Quinidine—malaria	0.000254	0.0013	CcSEcCtD
Sirolimus—Nervous system disorder—Quinine—malaria	0.000254	0.0013	CcSEcCtD
Sirolimus—Thrombocytopenia—Quinidine—malaria	0.000254	0.0013	CcSEcCtD
Sirolimus—Thrombocytopenia—Quinine—malaria	0.000254	0.0013	CcSEcCtD
Sirolimus—Palpitations—Quinidine barbiturate—malaria	0.000253	0.0013	CcSEcCtD
Sirolimus—Tachycardia—Quinidine—malaria	0.000253	0.0013	CcSEcCtD
Sirolimus—Tachycardia—Quinine—malaria	0.000253	0.0013	CcSEcCtD
Sirolimus—Palpitations—Pentoxifylline—malaria	0.000253	0.00129	CcSEcCtD
Sirolimus—Loss of consciousness—Quinidine barbiturate—malaria	0.000252	0.00129	CcSEcCtD
Sirolimus—ABCB1—liver—malaria	0.000252	0.00289	CbGeAlD
Sirolimus—Skin disorder—Quinidine—malaria	0.000252	0.00129	CcSEcCtD
Sirolimus—Skin disorder—Quinine—malaria	0.000252	0.00129	CcSEcCtD
Sirolimus—Pruritus—Sulfadiazine—malaria	0.000251	0.00129	CcSEcCtD
Sirolimus—Hyperhidrosis—Quinidine—malaria	0.000251	0.00128	CcSEcCtD
Sirolimus—Hyperhidrosis—Quinine—malaria	0.000251	0.00128	CcSEcCtD
Sirolimus—Anorexia—Quinidine—malaria	0.000247	0.00127	CcSEcCtD
Sirolimus—Anorexia—Quinine—malaria	0.000247	0.00127	CcSEcCtD
Sirolimus—Insomnia—Dapsone—malaria	0.000247	0.00127	CcSEcCtD
Sirolimus—Hypertension—Pentoxifylline—malaria	0.000247	0.00126	CcSEcCtD
Sirolimus—Hypotension—Clindamycin—malaria	0.000247	0.00126	CcSEcCtD
Sirolimus—Arthralgia—Quinidine barbiturate—malaria	0.000244	0.00125	CcSEcCtD
Sirolimus—Chest pain—Quinidine barbiturate—malaria	0.000244	0.00125	CcSEcCtD
Sirolimus—Myalgia—Quinidine barbiturate—malaria	0.000244	0.00125	CcSEcCtD
Sirolimus—Chest pain—Pentoxifylline—malaria	0.000244	0.00125	CcSEcCtD
Sirolimus—Myalgia—Pentoxifylline—malaria	0.000244	0.00125	CcSEcCtD
Sirolimus—Anxiety—Quinidine barbiturate—malaria	0.000243	0.00125	CcSEcCtD
Sirolimus—Diarrhoea—Sulfadiazine—malaria	0.000243	0.00124	CcSEcCtD
Sirolimus—Anxiety—Pentoxifylline—malaria	0.000243	0.00124	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000242	0.00124	CcSEcCtD
Sirolimus—Hypotension—Quinidine—malaria	0.000242	0.00124	CcSEcCtD
Sirolimus—Hypotension—Quinine—malaria	0.000242	0.00124	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000242	0.00124	CcSEcCtD
Sirolimus—Discomfort—Pentoxifylline—malaria	0.000241	0.00123	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Quinidine—malaria	0.000236	0.00121	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Quinine—malaria	0.000236	0.00121	CcSEcCtD
Sirolimus—Confusional state—Quinidine barbiturate—malaria	0.000236	0.00121	CcSEcCtD
Sirolimus—Dyspnoea—Clindamycin—malaria	0.000235	0.00121	CcSEcCtD
Sirolimus—Confusional state—Pentoxifylline—malaria	0.000235	0.00121	CcSEcCtD
Sirolimus—Oedema—Quinidine barbiturate—malaria	0.000234	0.0012	CcSEcCtD
Sirolimus—Anaphylactic shock—Pentoxifylline—malaria	0.000233	0.0012	CcSEcCtD
Sirolimus—Oedema—Pentoxifylline—malaria	0.000233	0.0012	CcSEcCtD
Sirolimus—Dyspepsia—Clindamycin—malaria	0.000233	0.00119	CcSEcCtD
Sirolimus—Infection—Pentoxifylline—malaria	0.000232	0.00119	CcSEcCtD
Sirolimus—Dyspnoea—Quinidine—malaria	0.000231	0.00118	CcSEcCtD
Sirolimus—Dyspnoea—Quinine—malaria	0.000231	0.00118	CcSEcCtD
Sirolimus—Shock—Quinidine barbiturate—malaria	0.00023	0.00118	CcSEcCtD
Sirolimus—Shock—Pentoxifylline—malaria	0.00023	0.00118	CcSEcCtD
Sirolimus—Nervous system disorder—Quinidine barbiturate—malaria	0.000229	0.00117	CcSEcCtD
Sirolimus—Thrombocytopenia—Quinidine barbiturate—malaria	0.000229	0.00117	CcSEcCtD
Sirolimus—Thrombocytopenia—Pentoxifylline—malaria	0.000229	0.00117	CcSEcCtD
Sirolimus—Tachycardia—Quinidine barbiturate—malaria	0.000228	0.00117	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Clindamycin—malaria	0.000228	0.00117	CcSEcCtD
Sirolimus—Tachycardia—Pentoxifylline—malaria	0.000228	0.00117	CcSEcCtD
Sirolimus—Skin disorder—Quinidine barbiturate—malaria	0.000227	0.00116	CcSEcCtD
Sirolimus—Skin disorder—Pentoxifylline—malaria	0.000227	0.00116	CcSEcCtD
Sirolimus—Hyperhidrosis—Quinidine barbiturate—malaria	0.000226	0.00116	CcSEcCtD
Sirolimus—Pain—Clindamycin—malaria	0.000226	0.00116	CcSEcCtD
Sirolimus—Constipation—Clindamycin—malaria	0.000226	0.00116	CcSEcCtD
Sirolimus—Hyperhidrosis—Pentoxifylline—malaria	0.000226	0.00116	CcSEcCtD
Sirolimus—Vomiting—Sulfadiazine—malaria	0.000226	0.00116	CcSEcCtD
Sirolimus—Decreased appetite—Quinidine—malaria	0.000225	0.00115	CcSEcCtD
Sirolimus—Decreased appetite—Quinine—malaria	0.000225	0.00115	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Quinidine—malaria	0.000224	0.00115	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Quinine—malaria	0.000224	0.00115	CcSEcCtD
Sirolimus—Rash—Sulfadiazine—malaria	0.000224	0.00115	CcSEcCtD
Sirolimus—Dermatitis—Sulfadiazine—malaria	0.000223	0.00114	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dapsone—malaria	0.000223	0.00114	CcSEcCtD
Sirolimus—Anorexia—Quinidine barbiturate—malaria	0.000223	0.00114	CcSEcCtD
Sirolimus—Anorexia—Pentoxifylline—malaria	0.000223	0.00114	CcSEcCtD
Sirolimus—Headache—Sulfadiazine—malaria	0.000222	0.00114	CcSEcCtD
Sirolimus—Hypotension—Quinidine barbiturate—malaria	0.000219	0.00112	CcSEcCtD
Sirolimus—Hypotension—Pentoxifylline—malaria	0.000218	0.00112	CcSEcCtD
Sirolimus—Gastrointestinal pain—Clindamycin—malaria	0.000216	0.00111	CcSEcCtD
Sirolimus—Abdominal pain—Dapsone—malaria	0.000216	0.00111	CcSEcCtD
Sirolimus—Body temperature increased—Dapsone—malaria	0.000216	0.00111	CcSEcCtD
Sirolimus—Feeling abnormal—Quinidine—malaria	0.000214	0.00109	CcSEcCtD
Sirolimus—Feeling abnormal—Quinine—malaria	0.000214	0.00109	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000213	0.00109	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000213	0.00109	CcSEcCtD
Sirolimus—Gastrointestinal pain—Quinidine—malaria	0.000212	0.00109	CcSEcCtD
Sirolimus—Gastrointestinal pain—Quinine—malaria	0.000212	0.00109	CcSEcCtD
Sirolimus—Insomnia—Pentoxifylline—malaria	0.000211	0.00108	CcSEcCtD
Sirolimus—Nausea—Sulfadiazine—malaria	0.000211	0.00108	CcSEcCtD
Sirolimus—Body temperature increased—Clindamycin—malaria	0.000209	0.00107	CcSEcCtD
Sirolimus—Abdominal pain—Clindamycin—malaria	0.000209	0.00107	CcSEcCtD
Sirolimus—Dyspnoea—Quinidine barbiturate—malaria	0.000208	0.00107	CcSEcCtD
Sirolimus—Dyspnoea—Pentoxifylline—malaria	0.000208	0.00107	CcSEcCtD
Sirolimus—Somnolence—Quinidine barbiturate—malaria	0.000208	0.00106	CcSEcCtD
Sirolimus—Somnolence—Pentoxifylline—malaria	0.000208	0.00106	CcSEcCtD
Sirolimus—Dyspepsia—Pentoxifylline—malaria	0.000205	0.00105	CcSEcCtD
Sirolimus—Body temperature increased—Quinidine—malaria	0.000205	0.00105	CcSEcCtD
Sirolimus—Abdominal pain—Quinine—malaria	0.000205	0.00105	CcSEcCtD
Sirolimus—Abdominal pain—Quinidine—malaria	0.000205	0.00105	CcSEcCtD
Sirolimus—Body temperature increased—Quinine—malaria	0.000205	0.00105	CcSEcCtD
Sirolimus—Decreased appetite—Quinidine barbiturate—malaria	0.000203	0.00104	CcSEcCtD
Sirolimus—Decreased appetite—Pentoxifylline—malaria	0.000203	0.00104	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000202	0.00103	CcSEcCtD
Sirolimus—Pain—Quinidine barbiturate—malaria	0.0002	0.00102	CcSEcCtD
Sirolimus—Constipation—Quinidine barbiturate—malaria	0.0002	0.00102	CcSEcCtD
Sirolimus—ABCB1—brain—malaria	0.0002	0.00229	CbGeAlD
Sirolimus—Constipation—Pentoxifylline—malaria	0.0002	0.00102	CcSEcCtD
Sirolimus—Hypersensitivity—Clindamycin—malaria	0.000195	0.000997	CcSEcCtD
Sirolimus—Feeling abnormal—Quinidine barbiturate—malaria	0.000193	0.000987	CcSEcCtD
Sirolimus—Feeling abnormal—Pentoxifylline—malaria	0.000192	0.000985	CcSEcCtD
Sirolimus—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000191	0.00098	CcSEcCtD
Sirolimus—Hypersensitivity—Quinidine—malaria	0.000191	0.000978	CcSEcCtD
Sirolimus—Hypersensitivity—Quinine—malaria	0.000191	0.000978	CcSEcCtD
Sirolimus—Gastrointestinal pain—Pentoxifylline—malaria	0.000191	0.000978	CcSEcCtD
Sirolimus—Asthenia—Clindamycin—malaria	0.00019	0.000971	CcSEcCtD
Sirolimus—Pruritus—Clindamycin—malaria	0.000187	0.000957	CcSEcCtD
Sirolimus—Asthenia—Quinine—malaria	0.000186	0.000952	CcSEcCtD
Sirolimus—Asthenia—Quinidine—malaria	0.000186	0.000952	CcSEcCtD
Sirolimus—Body temperature increased—Quinidine barbiturate—malaria	0.000185	0.000947	CcSEcCtD
Sirolimus—Abdominal pain—Quinidine barbiturate—malaria	0.000185	0.000947	CcSEcCtD
Sirolimus—Abdominal pain—Pentoxifylline—malaria	0.000185	0.000945	CcSEcCtD
Sirolimus—Body temperature increased—Pentoxifylline—malaria	0.000185	0.000945	CcSEcCtD
Sirolimus—Pruritus—Quinine—malaria	0.000183	0.000939	CcSEcCtD
Sirolimus—Pruritus—Quinidine—malaria	0.000183	0.000939	CcSEcCtD
Sirolimus—Diarrhoea—Clindamycin—malaria	0.000181	0.000926	CcSEcCtD
Sirolimus—Diarrhoea—Quinidine—malaria	0.000177	0.000908	CcSEcCtD
Sirolimus—Diarrhoea—Quinine—malaria	0.000177	0.000908	CcSEcCtD
Sirolimus—Dizziness—Clindamycin—malaria	0.000175	0.000895	CcSEcCtD
Sirolimus—Vomiting—Dapsone—malaria	0.000174	0.000889	CcSEcCtD
Sirolimus—Hypersensitivity—Quinidine barbiturate—malaria	0.000172	0.000883	CcSEcCtD
Sirolimus—Hypersensitivity—Pentoxifylline—malaria	0.000172	0.000881	CcSEcCtD
Sirolimus—Dizziness—Quinine—malaria	0.000171	0.000878	CcSEcCtD
Sirolimus—Dizziness—Quinidine—malaria	0.000171	0.000878	CcSEcCtD
Sirolimus—Headache—Dapsone—malaria	0.000171	0.000876	CcSEcCtD
Sirolimus—Vomiting—Clindamycin—malaria	0.000168	0.00086	CcSEcCtD
Sirolimus—Asthenia—Quinidine barbiturate—malaria	0.000168	0.000859	CcSEcCtD
Sirolimus—Asthenia—Pentoxifylline—malaria	0.000167	0.000858	CcSEcCtD
Sirolimus—Rash—Clindamycin—malaria	0.000167	0.000853	CcSEcCtD
Sirolimus—Dermatitis—Clindamycin—malaria	0.000166	0.000852	CcSEcCtD
Sirolimus—Headache—Clindamycin—malaria	0.000165	0.000848	CcSEcCtD
Sirolimus—Pruritus—Quinidine barbiturate—malaria	0.000165	0.000848	CcSEcCtD
Sirolimus—Pruritus—Pentoxifylline—malaria	0.000165	0.000846	CcSEcCtD
Sirolimus—Vomiting—Quinidine—malaria	0.000165	0.000844	CcSEcCtD
Sirolimus—Vomiting—Quinine—malaria	0.000165	0.000844	CcSEcCtD
Sirolimus—Rash—Quinine—malaria	0.000163	0.000837	CcSEcCtD
Sirolimus—Rash—Quinidine—malaria	0.000163	0.000837	CcSEcCtD
Sirolimus—Dermatitis—Quinine—malaria	0.000163	0.000836	CcSEcCtD
Sirolimus—Dermatitis—Quinidine—malaria	0.000163	0.000836	CcSEcCtD
Sirolimus—Headache—Quinidine—malaria	0.000162	0.000832	CcSEcCtD
Sirolimus—Headache—Quinine—malaria	0.000162	0.000832	CcSEcCtD
Sirolimus—Nausea—Dapsone—malaria	0.000162	0.000831	CcSEcCtD
Sirolimus—Diarrhoea—Quinidine barbiturate—malaria	0.00016	0.00082	CcSEcCtD
Sirolimus—Diarrhoea—Pentoxifylline—malaria	0.00016	0.000818	CcSEcCtD
Sirolimus—Nausea—Clindamycin—malaria	0.000157	0.000804	CcSEcCtD
Sirolimus—Dizziness—Quinidine barbiturate—malaria	0.000155	0.000792	CcSEcCtD
Sirolimus—Dizziness—Pentoxifylline—malaria	0.000154	0.000791	CcSEcCtD
Sirolimus—Nausea—Quinidine—malaria	0.000154	0.000788	CcSEcCtD
Sirolimus—Nausea—Quinine—malaria	0.000154	0.000788	CcSEcCtD
Sirolimus—Vomiting—Quinidine barbiturate—malaria	0.000149	0.000762	CcSEcCtD
Sirolimus—Vomiting—Pentoxifylline—malaria	0.000148	0.00076	CcSEcCtD
Sirolimus—Rash—Quinidine barbiturate—malaria	0.000147	0.000755	CcSEcCtD
Sirolimus—Dermatitis—Quinidine barbiturate—malaria	0.000147	0.000755	CcSEcCtD
Sirolimus—Rash—Pentoxifylline—malaria	0.000147	0.000754	CcSEcCtD
Sirolimus—Dermatitis—Pentoxifylline—malaria	0.000147	0.000753	CcSEcCtD
Sirolimus—Headache—Quinidine barbiturate—malaria	0.000147	0.00075	CcSEcCtD
Sirolimus—Headache—Pentoxifylline—malaria	0.000146	0.000749	CcSEcCtD
Sirolimus—Nausea—Quinidine barbiturate—malaria	0.000139	0.000712	CcSEcCtD
Sirolimus—Nausea—Pentoxifylline—malaria	0.000139	0.00071	CcSEcCtD
Sirolimus—FKBP1A—Spinal Cord Injury—TNF—malaria	0.000136	0.00202	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	0.000136	0.00201	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CISH—malaria	0.000135	0.00201	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CR1—malaria	0.000135	0.002	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—malaria	0.00013	0.00193	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ACKR1—malaria	0.00013	0.00193	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—FCGR2A—malaria	0.000129	0.00192	CbGpPWpGaD
Sirolimus—MTOR—TSLP Signaling Pathway—IL6—malaria	0.000129	0.00192	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PKLR—malaria	0.000129	0.00191	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—IL1B—malaria	0.000128	0.0019	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—IL2—malaria	0.000128	0.0019	CbGpPWpGaD
Sirolimus—FGF2—Immune System—FCGR2B—malaria	0.000128	0.00189	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—FCGR2A—malaria	0.000123	0.00183	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL10—malaria	0.00012	0.00177	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—CD40LG—malaria	0.00012	0.00177	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL4—malaria	0.000116	0.00173	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—malaria	0.000116	0.00172	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—KDR—malaria	0.000115	0.00171	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—G6PD—malaria	0.000115	0.0017	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TLR9—malaria	0.000115	0.0017	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TIRAP—malaria	0.000114	0.00169	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—HLA-B—malaria	0.000114	0.00169	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ICAM1—malaria	0.00011	0.00164	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—IL6—malaria	0.00011	0.00163	CbGpPWpGaD
Sirolimus—FGF2—IRS-mediated signalling—IL6—malaria	0.000108	0.00161	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—FAS—malaria	0.000107	0.00159	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	0.000106	0.00157	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CR1—malaria	0.000106	0.00157	CbGpPWpGaD
Sirolimus—FGF2—IRS-related events—IL6—malaria	0.000105	0.00157	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TLR9—malaria	0.000105	0.00155	CbGpPWpGaD
Sirolimus—FGF2—IRS-related events triggered by IGF1R—IL6—malaria	0.000105	0.00155	CbGpPWpGaD
Sirolimus—FGF2—Insulin receptor signalling cascade—IL6—malaria	0.000102	0.00151	CbGpPWpGaD
Sirolimus—FGF2—IGF1R signaling cascade—IL6—malaria	0.000102	0.00151	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	0.000101	0.00149	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CISH—malaria	0.0001	0.00149	CbGpPWpGaD
Sirolimus—FGF2—Disease—PKLR—malaria	9.77e-05	0.00145	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	9.55e-05	0.00142	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ACKR1—malaria	9.52e-05	0.00141	CbGpPWpGaD
Sirolimus—MTOR—Immune System—FCGR2B—malaria	9.47e-05	0.00141	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—malaria	9.28e-05	0.00138	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—FCGR2A—malaria	9.16e-05	0.00136	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TLR9—malaria	8.99e-05	0.00133	CbGpPWpGaD
Sirolimus—FGF2—Disease—G6PD—malaria	8.71e-05	0.00129	CbGpPWpGaD
Sirolimus—FGF2—Signaling by Insulin receptor—IL6—malaria	8.45e-05	0.00125	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TIRAP—malaria	8.44e-05	0.00125	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—DHFR—malaria	8.13e-05	0.00121	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—DHODH—malaria	8.1e-05	0.0012	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—CD36—malaria	8.05e-05	0.0012	CbGpPWpGaD
Sirolimus—MTOR—IRS-mediated signalling—IL6—malaria	8.05e-05	0.00119	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL18—malaria	8.02e-05	0.00119	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD40LG—malaria	7.99e-05	0.00119	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—malaria	7.97e-05	0.00118	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD8A—malaria	7.9e-05	0.00117	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CR1—malaria	7.85e-05	0.00117	CbGpPWpGaD
Sirolimus—MTOR—IRS-related events—IL6—malaria	7.83e-05	0.00116	CbGpPWpGaD
Sirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—malaria	7.76e-05	0.00115	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TLR9—malaria	7.67e-05	0.00114	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—HLA-B—malaria	7.6e-05	0.00113	CbGpPWpGaD
Sirolimus—MTOR—Insulin receptor signalling cascade—IL6—malaria	7.55e-05	0.00112	CbGpPWpGaD
Sirolimus—MTOR—IGF1R signaling cascade—IL6—malaria	7.55e-05	0.00112	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—IL6—malaria	7.51e-05	0.00112	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD36—malaria	7.45e-05	0.00111	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—DHODH—malaria	7.43e-05	0.0011	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	7.36e-05	0.00109	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD40LG—malaria	7.32e-05	0.00109	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—SCARB1—malaria	7.31e-05	0.00109	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—HLA-B—malaria	7.25e-05	0.00108	CbGpPWpGaD
Sirolimus—MTOR—Disease—PKLR—malaria	7.25e-05	0.00108	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD8A—malaria	7.24e-05	0.00107	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—IL6—malaria	7.23e-05	0.00107	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ACKR1—malaria	7.21e-05	0.00107	CbGpPWpGaD
Sirolimus—FGF2—Immune System—FCGR2A—malaria	7.19e-05	0.00107	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CD36—malaria	7.11e-05	0.00106	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IFNG—malaria	7.03e-05	0.00104	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TNF—malaria	7.03e-05	0.00104	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—HLA-B—malaria	6.97e-05	0.00103	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—KDR—malaria	6.96e-05	0.00103	CbGpPWpGaD
Sirolimus—FGF2—Downstream signaling of activated FGFR—IL6—malaria	6.92e-05	0.00103	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—SLC4A1—malaria	6.89e-05	0.00102	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD36—malaria	6.83e-05	0.00101	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—IL6—malaria	6.81e-05	0.00101	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—malaria	6.79e-05	0.00101	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CRP—malaria	6.72e-05	0.000997	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—malaria	6.69e-05	0.000993	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR9—malaria	6.67e-05	0.000991	CbGpPWpGaD
Sirolimus—FGF2—Downstream signal transduction—IL6—malaria	6.5e-05	0.000965	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—DECR1—malaria	6.48e-05	0.000961	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR—IL6—malaria	6.47e-05	0.000961	CbGpPWpGaD
Sirolimus—MTOR—Disease—G6PD—malaria	6.46e-05	0.000959	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—TLR4—malaria	6.44e-05	0.000956	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB2—IL6—malaria	6.44e-05	0.000956	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CRP—malaria	6.41e-05	0.000952	CbGpPWpGaD
Sirolimus—FGF2—DAP12 signaling—IL6—malaria	6.41e-05	0.000951	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—HPGDS—malaria	6.4e-05	0.00095	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SLC4A1—malaria	6.32e-05	0.000938	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—IL6—malaria	6.32e-05	0.000938	CbGpPWpGaD
Sirolimus—MTOR—Signaling by Insulin receptor—IL6—malaria	6.27e-05	0.000931	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL1B—malaria	6.27e-05	0.000931	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL2—malaria	6.25e-05	0.000927	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—ICAM1—malaria	6.18e-05	0.000917	CbGpPWpGaD
Sirolimus—FGF2—Disease—DHFR—malaria	6.16e-05	0.000914	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—TLR4—malaria	6.15e-05	0.000912	CbGpPWpGaD
Sirolimus—FGF2—DAP12 interactions—IL6—malaria	6.03e-05	0.000895	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR in disease—IL6—malaria	6.03e-05	0.000895	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—malaria	6.03e-05	0.000895	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR—IL6—malaria	5.98e-05	0.000887	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—DECR1—malaria	5.94e-05	0.000882	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR in Cancer—IL6—malaria	5.92e-05	0.000879	CbGpPWpGaD
Sirolimus—FGF2—Signaling by PDGF—IL6—malaria	5.9e-05	0.000875	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—HBB—malaria	5.86e-05	0.000869	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TLR9—malaria	5.82e-05	0.000863	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—ICAM1—malaria	5.66e-05	0.00084	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD40LG—malaria	5.44e-05	0.000807	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—HLA-B—malaria	5.38e-05	0.000799	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—HBB—malaria	5.38e-05	0.000798	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD8A—malaria	5.37e-05	0.000798	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—DHODH—malaria	5.37e-05	0.000798	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—IL6—malaria	5.37e-05	0.000797	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ACKR1—malaria	5.35e-05	0.000795	CbGpPWpGaD
Sirolimus—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—malaria	5.34e-05	0.000793	CbGpPWpGaD
Sirolimus—MTOR—Immune System—FCGR2A—malaria	5.34e-05	0.000792	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	5.29e-05	0.000785	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD36—malaria	5.28e-05	0.000783	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PKLR—malaria	5.22e-05	0.000775	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—HLA-B—malaria	5.17e-05	0.000767	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling of activated FGFR—IL6—malaria	5.14e-05	0.000762	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD36—malaria	5.07e-05	0.000752	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—IL6—malaria	5.05e-05	0.00075	CbGpPWpGaD
Sirolimus—MTOR—Downstream signal transduction—IL6—malaria	4.83e-05	0.000716	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR—IL6—malaria	4.8e-05	0.000713	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PKLR—malaria	4.79e-05	0.000711	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB2—IL6—malaria	4.78e-05	0.000709	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CRP—malaria	4.76e-05	0.000706	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—IL6—malaria	4.76e-05	0.000706	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IFNG—malaria	4.7e-05	0.000697	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—G6PD—malaria	4.65e-05	0.000691	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—malaria	4.59e-05	0.000681	CbGpPWpGaD
Sirolimus—MTOR—Disease—DHFR—malaria	4.57e-05	0.000678	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SLC4A1—malaria	4.57e-05	0.000678	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TLR4—malaria	4.56e-05	0.000677	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TNF—malaria	4.55e-05	0.000675	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD4—malaria	4.54e-05	0.000674	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—IL6—malaria	4.47e-05	0.000664	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—IL6—malaria	4.47e-05	0.000664	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—malaria	4.47e-05	0.000664	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL18—malaria	4.46e-05	0.000662	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD40LG—malaria	4.44e-05	0.000659	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—IL6—malaria	4.43e-05	0.000658	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—IL6—malaria	4.39e-05	0.000652	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD8A—malaria	4.39e-05	0.000652	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—IL6—malaria	4.38e-05	0.000649	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CD4—malaria	4.33e-05	0.000643	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TLR9—malaria	4.32e-05	0.000641	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—DECR1—malaria	4.3e-05	0.000638	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—G6PD—malaria	4.27e-05	0.000634	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HLA-B—malaria	4.23e-05	0.000627	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ICAM1—malaria	4.2e-05	0.000623	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1B—malaria	4.19e-05	0.000622	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL2—malaria	4.18e-05	0.00062	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—KDR—malaria	4.16e-05	0.000618	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD4—malaria	4.16e-05	0.000617	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS2—malaria	4.15e-05	0.000616	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD36—malaria	4.14e-05	0.000615	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—IL6—malaria	4.11e-05	0.00061	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—DHODH—malaria	4.06e-05	0.000602	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—malaria	3.96e-05	0.000588	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HBB—malaria	3.89e-05	0.000577	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CRP—malaria	3.73e-05	0.000554	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TLR4—malaria	3.58e-05	0.000531	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—HPGDS—malaria	3.55e-05	0.000527	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PKLR—malaria	3.46e-05	0.000514	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC4A1—malaria	3.45e-05	0.000512	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ICAM1—malaria	3.43e-05	0.00051	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL18—malaria	3.31e-05	0.000491	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD40LG—malaria	3.3e-05	0.000489	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—DHFR—malaria	3.29e-05	0.000489	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—malaria	3.29e-05	0.000488	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD8A—malaria	3.26e-05	0.000484	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—SCARB1—malaria	3.26e-05	0.000484	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—HPGDS—malaria	3.26e-05	0.000483	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL6—malaria	3.25e-05	0.000482	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—DECR1—malaria	3.24e-05	0.000481	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD4—malaria	3.21e-05	0.000477	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS2—malaria	3.14e-05	0.000467	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-B—malaria	3.14e-05	0.000465	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD4—malaria	3.09e-05	0.000458	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—G6PD—malaria	3.09e-05	0.000458	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD36—malaria	3.07e-05	0.000456	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CD4—malaria	3.07e-05	0.000456	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—KDR—malaria	3.05e-05	0.000453	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—IL6—malaria	3.05e-05	0.000452	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—DHFR—malaria	3.02e-05	0.000448	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SCARB1—malaria	2.99e-05	0.000444	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HBB—malaria	2.93e-05	0.000435	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—malaria	2.77e-05	0.000411	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL2—malaria	2.7e-05	0.000401	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR4—malaria	2.66e-05	0.000394	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—malaria	2.65e-05	0.000394	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PKLR—malaria	2.61e-05	0.000388	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IFNG—malaria	2.61e-05	0.000388	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ICAM1—malaria	2.55e-05	0.000378	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD4—malaria	2.52e-05	0.000374	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—DHODH—malaria	2.5e-05	0.000371	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—malaria	2.45e-05	0.000364	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HPGDS—malaria	2.35e-05	0.000349	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—malaria	2.34e-05	0.000348	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS2—malaria	2.33e-05	0.000346	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—malaria	2.33e-05	0.000346	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD4—malaria	2.33e-05	0.000346	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—G6PD—malaria	2.33e-05	0.000346	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL2—malaria	2.32e-05	0.000345	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—KDR—malaria	2.32e-05	0.000344	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.25e-05	0.000333	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—DHFR—malaria	2.18e-05	0.000324	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SCARB1—malaria	2.16e-05	0.000321	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC4A1—malaria	2.12e-05	0.000315	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CD36—malaria	2.04e-05	0.000303	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—DECR1—malaria	2e-05	0.000296	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2—malaria	1.98e-05	0.000294	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNG—malaria	1.94e-05	0.000288	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CD36—malaria	1.88e-05	0.000278	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD4—malaria	1.87e-05	0.000278	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HBB—malaria	1.81e-05	0.000268	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HPGDS—malaria	1.78e-05	0.000264	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—malaria	1.74e-05	0.000258	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—malaria	1.73e-05	0.000257	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD4—malaria	1.73e-05	0.000257	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2—malaria	1.72e-05	0.000256	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—KDR—malaria	1.72e-05	0.000255	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—malaria	1.66e-05	0.000247	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—DHFR—malaria	1.65e-05	0.000245	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SCARB1—malaria	1.63e-05	0.000242	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PKLR—malaria	1.61e-05	0.000239	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—malaria	1.59e-05	0.000236	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2—malaria	1.5e-05	0.000223	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—G6PD—malaria	1.43e-05	0.000213	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—malaria	1.36e-05	0.000203	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CD36—malaria	1.36e-05	0.000201	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—malaria	1.26e-05	0.000187	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—malaria	1.16e-05	0.000173	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2—malaria	1.11e-05	0.000165	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HPGDS—malaria	1.09e-05	0.000162	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CD36—malaria	1.02e-05	0.000152	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—DHFR—malaria	1.02e-05	0.000151	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—malaria	1.01e-05	0.00015	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SCARB1—malaria	1e-05	0.000149	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—malaria	9.35e-06	0.000139	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—malaria	8.82e-06	0.000131	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—malaria	6.55e-06	9.72e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CD36—malaria	6.31e-06	9.36e-05	CbGpPWpGaD
